pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Fauci warns of public "selective amnesia" on Covid, hints at upcoming book as STAT newsletter covers Trump drug pricing deals

Sep 3, 2026·read at STAT ↗Neutral

STAT's twice‑weekly D.C. Diagnosis newsletter continues to blend health policy analysis with behind‑the‑scenes commentary, offering readers insight into current political debates.

In a recent interview, former infectious‑disease chief Anthony Fauci said Americans show "selective amnesia" about the Covid‑19 pandemic, a view he says shapes current attitudes toward measures such as masking and lockdowns. He also revealed he is working on a new book that will explore these themes further.

The newsletter also examines President Trump’s latest drug pricing initiatives, breaking down the details of the deals and their potential impact on the pharmaceutical market.

Readers are invited to submit tips and follow the author on Signal, while subscription options remain available for those seeking deeper analysis and exclusive content.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Fauci speaks, and writes”

read at STAT ↗
434 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVARTISUltragenyx Pharmaceutical Inc.
topics
BTKCardiologyHematologyMultiple SclerosisOncologyOphthalmologyRare Disease

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 23Fierce Biotech Layoff Tracker 2026: Novartis nixes Swiss site; TScan telegraphs 75% headcount dropFierce Biotech
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 1h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 2d agoNovartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety eventsBioSpace